Last reviewed · How we verify

NCT06154421: FLEX

Metacarpophalangeal Joint Prostheses in Hand Surgery.

Status unknown Last updated 5 January 2024
What this trial tests

trial testing Metacarpophalangeal joint prostheses in Osteoarthritis Metacarpophalangeal Joint in 100 participants. Status unknown.

Timeline
4 January 2024
Primary endpoint
30 April 2024
30 June 2024

Quick facts

Lead sponsorWaldfriede Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date4 January 2024
Primary completion30 April 2024
Estimated completion30 June 2024
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Waldfriede Hospital

Who can join

Adults 18 to 90, any sex, with Osteoarthritis Metacarpophalangeal Joint or Rheumatoid Arthritis Metacarpophalangeal Joint. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary working hypothesis of this study is whether KeriFlex® metacarpophalangeal joint prostheses provide an equivalent result to Swanson finger joint implants in patients with rheumatoid arthritis or post-traumatic osteoarthritis. Functional status will be measured by Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire no earlier than 1 year after surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Waldfriede Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06154421.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing